PR NEWSWIRE

Previous Stories

Novavax Nuvaxovid™ COVID-19 Vaccine Granted Provisional Registration in Australia for Use in Adolescents Aged 12 Through 17

Jul 26 2022 - PR NewsWire

Nuvaxovid™ is the first protein-based COVID-19 vaccine available for use in adolescents aged 12 through 17 in Australia GAITHERSBURG, Md.,…


Security Matters Announces Business Combination with Lionheart III Corp, Expecting Valuation at US$360 Million on Nasdaq Listing

Jul 26 2022 - PR NewsWire

MELBOURNE, July 26, 2022 /PRNewswire/ —  Australian technology company Security Matters Ltd. (ASX: SMX) announces its business combination with Lionheart III…


Telstra and Microsoft sign five-year strategic agreement to support Australia’s digital growth

Jul 26 2022 - PR NewsWire

Empowering a nation: companies set out ambitious deal and plans SYDNEY, Australia, July 26, 2022 /PRNewswire/ – Today, Telstra and Microsoft…


theLotter: Australians are in a frenzy to place orders for tonight’s US Mega Millions’ AU$1.14 billion jackpot draw

Jul 26 2022 - PR NewsWire

SYDNEY, July 26, 2022 /PRNewswire/ — theLotter Australia, recently licensed by the Northern Territory Government, launched a few months ago….


Discover Malaysia: Trip.com and Tourism Malaysia offer Australian travellers return flights to Malaysia from $488

Jul 26 2022 - PR NewsWire

SYDNEY, July 26, 2022 /PRNewswire/ – Trip.com, the global travel services provider, has partnered with Tourism Malaysia to offer Australian travellers…


University of Technology Sydney builds largest startup community in Australia

Jul 26 2022 - PR NewsWire

UTS extends support to almost 500 student and alumni-run startups as part of the university’s flagship entrepreneurship program. SYDNEY, July…


VisualCortex and University of Wollongong partner to drive computer vision innovation and industry – research collaboration

Jul 25 2022 - PR NewsWire

VisualCortex signs mutual non-disclosure agreement with the University of Wollongong’s SMART Infrastructure Facility, joining the Hub for Artificial Intelligence of…


Infosys: Industry leading revenue growth in Q1 lays robust foundation for the year

Jul 25 2022 - PR NewsWire

 -  FY 23 Revenue guidance increased to 14%-16%.  -  Margin guidance retained at 21%-23% BENGALURU, India, July 25, 2022 /PRNewswire/…


US FDA APPROVES QBIOTICS INVESTIGATIONAL NEW DRUG APPLICATION TO INITIATE TIGILANOL TIGLATE SOFT TISSUE SARCOMA PHASE II TRIAL

Jul 25 2022 - PR NewsWire

Investigational new drug (IND) approval received by QBiotics, to initiate a Phase II clinical trial investigating tigilanol tiglate in the…


Alterity Therapeutics: Appendix 4C – Q4 FY22 Quarterly Cash Flow Report

Jul 22 2022 - PR NewsWire

Phase 2 clinical trial for ATH434 commences in New Zealand and patient enrolment begins Regulatory approval from the U.K. and…


Analyse The Market From A Different Angle